Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …

Primary liver cancer is one of the most common malignant tumours worldwide; it caused
approximately 830,000 deaths in 2020. Hepatocellular carcinoma (HCC) is the most …

Methionine restriction, a dietary regimen that protects against metabolic diseases and aging,
represses cancer growth and improves cancer therapy. However, the response of different …

Hepatocellular carcinoma (HCC) accounts for 90% of liver tumours and is one of the leading
causes of mortality. Cirrhosis due to viral hepatitis, alcohol or steatohepatitis is the major risk …

Hepatocellular carcinoma (HCC) is the second leading cause of death due to cancer.
Although there are different treatment options, these strategies are not efficient in terms of …

Recent experiments have evidenced sub-nanometer resolution in plasmonic-enhanced
probe spectroscopy. Such a high resolution cannot be simply explained using the commonly …

Cytostatic effects of doxorubicin in clinically applied doses are often inadequate and limited
by systemic toxicity. The main objective of this in vitro study was to determine the anti …

Targeted radionuclide therapy, known as molecular radiotherapy is a novel therapeutic
module in cancer medicine. β-radiating radionuclides have definite impact on target cells via …

Abstract Protein phosphatase 2A (PP2A) is a major serine/threonine phosphatase. This
enzyme is involved in a plethora of cellular processes, including apoptosis, autophagy, cell …

Hepatocellular carcinoma (HCC) is an inflammation-related malignant tumor that develops
from underlying cirrhosis. As HCC is a common tumor seen in clinical practice, its prevention …